Literature DB >> 19584147

Prevention of radiation-induced oral mucositis after adenoviral vector-mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands.

Changyu Zheng1, Ana P Cotrim, Abraham N Sunshine, Takayuki Sugito, Lina Liu, Anastasia Sowers, James B Mitchell, Bruce J Baum.   

Abstract

PURPOSE: The study aims to evaluate if human keratinocyte growth factor (hKGF), secreted after transduction of murine salivary glands with adenoviral vectors, can prevent oral mucositis resulting from radiation. EXPERIMENTAL
DESIGN: Two serotype 5 adenoviral vectors encoding hKGF were constructed: AdEF1alpha-hKGF and AdLTR(2)EF1alpha-hKGF. Female C3H mice, 8 weeks old, were irradiated by single (22.5 Gy) or fractionated (5 x 8 Gy for 5 days) doses to induce oral mucositis (ulcers on tongue). One day before irradiation, the above viral vectors or an empty vector, Adcontrol, was given (10(10) particles per gland) to both submandibular glands by retrograde ductal instillation. Each experiment included five groups: no irradiation and irradiation (+/-Adcontrol, AdEF1alpha-hKGF, or AdLTR(2)EF1alpha-hKGF). Blood, saliva, submandibular glands, and tongue were collected on day 7 for single-dose studies or day 10 for fractionated dosing. hKGF levels were measured by ELISA.
RESULTS: In three separate single-dose irradiation experiments, lingual ulcers were dramatically reduced after either KGF-expressing vector. Similarly, in two separate fractionated irradiation experiments, the hKGF-expressing vectors completely prevented ulcer formation. QPCR data indicated that approximately 10(7) to 10(8) particles of each vector remained in the targeted submandibular glands at the terminal time. Transgenic hKGF protein was found at high levels in saliva, serum, and submandibular gland extracts.
CONCLUSIONS: hKGF gene transfer to salivary glands prevented radiation-induced oral mucositis in mice. This proof of concept study suggests that transgenic hKGF secreted from transduced salivary glands may be useful clinically to prevent oral mucositis caused by radiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584147      PMCID: PMC2769927          DOI: 10.1158/1078-0432.CCR-09-0819

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  44 in total

1.  Evaluation of radiation-induced oral mucositis by optical coherence tomography.

Authors:  Thierry M Muanza; Ana P Cotrim; Mathew McAuliffe; Anastasia L Sowers; Bruce J Baum; John A Cook; Felix Feldchtein; Paul Amazeen; C Norman Coleman; James B Mitchell
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

Review 2.  Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy.

Authors:  Marie-Thérèse Genot; Jean Klastersky
Journal:  Curr Opin Oncol       Date:  2005-05       Impact factor: 3.645

3.  Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.

Authors:  A Amalfitano; J S Chamberlain
Journal:  Gene Ther       Date:  1997-03       Impact factor: 5.250

4.  The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.

Authors:  Liguang Chen; David M Brizel; Zahid N Rabbani; Thaddeus V Samulski; Catherine L Farrell; Nicole Larrier; Mitchell S Anscher; Zeljko Vujaskovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

5.  Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.

Authors:  Changyu Zheng; Bruce J Baum
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

Review 6.  Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.

Authors:  Paul W Finch; Jeffrey S Rubin
Journal:  J Natl Cancer Inst       Date:  2006-06-21       Impact factor: 13.506

7.  Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.

Authors:  Rachel J Gibson; Joanne M Bowen; Dorothy M K Keefe
Journal:  Int J Cancer       Date:  2005-09-01       Impact factor: 7.396

8.  Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice.

Authors:  C L Farrell; K L Rex; S A Kaufman; C R Dipalma; J N Chen; S Scully; D L Lacey
Journal:  Int J Radiat Biol       Date:  1999-05       Impact factor: 2.694

9.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

View more
  22 in total

Review 1.  Gene therapy for radioprotection.

Authors:  W H Everett; D T Curiel
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

2.  Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands.

Authors:  Changyu Zheng; Ana P Cotrim; Anne Rowzee; William Swaim; Anastasia Sowers; James B Mitchell; Bruce J Baum
Journal:  Clin Cancer Res       Date:  2011-03-02       Impact factor: 12.531

3.  A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.

Authors:  Changyu Zheng; Ana P Cotrim; Nikolay Nikolov; Fumi Mineshiba; William Swaim; Bruce J Baum
Journal:  Hum Gene Ther Methods       Date:  2012-07-20       Impact factor: 2.396

Review 4.  Salivary epithelial cells: an unassuming target site for gene therapeutics.

Authors:  Paola Perez; Anne M Rowzee; Changyu Zheng; Janik Adriaansen; Bruce J Baum
Journal:  Int J Biochem Cell Biol       Date:  2010-02-26       Impact factor: 5.085

5.  Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.

Authors:  P Perez; J Adriaansen; C M Goldsmith; C Zheng; B J Baum
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

6.  Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis.

Authors:  Qunzhou Zhang; Andrew L Nguyen; Shihong Shi; Colin Hill; Petra Wilder-Smith; Tatiana B Krasieva; Anh D Le
Journal:  Stem Cells Dev       Date:  2011-07-28       Impact factor: 3.272

7.  Bone Marrow-derived Cell Therapy for Oral Mucosal Repair after Irradiation.

Authors:  T I; Y Sumita; T Minamizato; M Umebayashi; Y Liu; S D Tran; I Asahina
Journal:  J Dent Res       Date:  2014-06-30       Impact factor: 6.116

8.  Pharmacological protection from radiation ± cisplatin-induced oral mucositis.

Authors:  Ana P Cotrim; Masanobu Yoshikawa; Abraham N Sunshine; Changyu Zheng; Anastasia L Sowers; Angela D Thetford; John A Cook; James B Mitchell; Bruce J Baum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

9.  Inhibition of caspases protects mice from radiation-induced oral mucositis and abolishes the cleavage of RNA-binding protein HuR.

Authors:  Sudha Talwar; Reniqua House; Santhanalakshmi Sundaramurthy; Sundaravadivel Balasubramanian; Hong Yu; Viswanathan Palanisamy
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 10.  Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.

Authors:  Judith E Raber-Durlacher; Inger von Bültzingslöwen; Richard M Logan; Joanne Bowen; Abdul Rahman Al-Azri; Hele Everaus; Erich Gerber; Jesùs Garcia Gomez; Bo G Pettersson; Yoshihiko Soga; Fred K L Spijkervet; Wim J E Tissing; Joel B Epstein; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2012-09-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.